Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-18-032341)

Filing Details

Accession Number:: 0001140361-18-032341
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-13 13:36:51
Reporting Period:: 2018-07-11

Accepted Time:: 2018-07-13 13:36:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1447028	Arbutus Biopharma Corp	ABUS	Pharmaceutical Preparations (2834)	980597776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1635324	J. Michael Sofia	C/O Arbutus Biopharma Corp. Suite 100, 8900 Glenlyon Parkway Burnaby A1 V5J 5J8	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2018-07-11	10,000	$10.00	1,503,403	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	171,412	Indirect	Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 22, 2014

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.